Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps "Mealtimes prove to be one of the ...

Two years after submitting the MiniMed 780G system for FDA approval, Medtronic finally secured the agency’s signoff to begin selling it in the U.S.

Data Medtronic unveiled at the ADA conference this weekend tout the benefits of its newly FDA-approved MiniMed 780G insulin pump for kids and teens.

Medtronic (NYSE:MDT) said it has voluntarily recalled its MiniMed 600 and 700 series insulin pumps over reports of shortened battery life. The medical device maker said an investigation into the ...

Patients urged to carry extra batteries as Medtronic recall affects 24,595 insulin pumps that may stop delivering insulin sooner than expected.

Medtronic plc ’s MDT most advanced automated insulin delivery (AID) system, MiniMed 780G, was recently recognized by the Fast Company in the Best World-Changing Idea, North America category as ...

Medtronic has issued an urgent medical device correction letter warning users of the MiniMed 600 and 700 series of insulin pumps of an increased risk for shorter-than-expected battery life ...

(RTTNews) - Medtronic plc (MDT) on Thursday reported results from the ADAPT study of its MiniMed 780G insulin pump, that continuously monitors and automatically adjusts insulin dosages round the ...

References: FDA approves Medtronic MiniMed ™ 780G System – world’s first insulin pump with meal detection technology* featuring 5-minute auto corrections†§. News release. Medtronic.

Users of one insulin pump system are being urged to take precautions after a cybersecurity risk was discovered that could put them at risk.

The MiniMed 780G system features the lowest glucose target setting (as low as 100 mg/dL) in any automated insulin pump on the market 1 and one that more closely mirrors the average glucose of ...